Literature DB >> 4021228

Dopaminergic modulation of the renal effect of arginine-vasopressin in water-loaded rats.

S Koyama, M Sasaki, T Setoyama, K Takahashi, K Togashi, K Suzuki, N Kakki, M Imai.   

Abstract

In order to confirm whether dopamine inhibits the antidiuretic action of vasopressin in mammalian kidney, we examined interactions among arginine vasopressin (AVP), dopamine and haloperidol in water-loaded ethanol anesthetized rats. The submaximal dose of AVP causing antidiuresis was 80 microU in this preparation. Dopamine at the doses of 0.11, 1.1 and 11 micrograms/100 g body weight (i.v.) inhibited the antidiuretic effect of 80 microU AVP by 18 +/- 7, 27 +/- 6 and 36 +/- 14%, respectively. The effect of 1.1 micrograms/100 g body weight dopamine in inhibiting the action of AVP was completely reversed by haloperidol at 2.3 micrograms/100 g body weight. Single administration of dopamine or haloperidol was without effect on urine flow. These observations support the view that dopamine inhibits the antidiuretic action of vasopressin by dopaminergic receptors also in the mammalian kidney.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4021228     DOI: 10.1254/jjp.38.25

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  3 in total

1.  Effects of proteolytic enzyme inhibitors on the nasal absorption of vasopressin and an analogue.

Authors:  K Morimoto; H Yamaguchi; Y Iwakura; M Miyazaki; E Nakatani; T Iwamoto; Y Ohashi; Y Nakai
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

2.  The effects of intravenous L-dopa on plasma renin activity, renal function, and blood pressure in man.

Authors:  D Worth; J Harvey; J Brown; M Lee
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Effects of viscous hyaluronate-sodium solutions on the nasal absorption of vasopressin and an analogue.

Authors:  K Morimoto; H Yamaguchi; Y Iwakura; K Morisaka; Y Ohashi; Y Nakai
Journal:  Pharm Res       Date:  1991-04       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.